Identifying when CML progresses to a deadlier form of the disease

[Guest guest]

Scientists at the s Cancer Center at the University of California, San

Diego, Stanford University School of Medicine and other centers have identified

a mechanism by which a chronic form of leukemia can progress into a deadlier

stage of the disease. The findings may provide physicians with an indicator of

when this type of cancer - chronic myeloid leukemia (CML) - is progressing,

enabling them to make more accurate prognoses for the disease and improved

treatment choices.

" If we can predict when a patient is moving from the chronic phase in CML to the

blast crisis stage, then we can hopefully intervene before it's too late, " said

Catriona H.M. son, MD, PhD, assistant professor of medicine at the UC San

Diego School of Medicine and Director for Stem Cell Research at the s UCSD

Cancer Center. I think this will interest you.

http://ucsdnews.ucsd.edu/newsrel/health/02-09son.asp

Blessings,

Lottie